A Phase I/Ii Study Of Eribulin Mesilate (Eri) Plus Irinotecan (Iri) In Children With Refractory Or Recurrent Solid Tumors.Michela Casanova,Christof Kramm,Dirk Reinhardt,Franco Locatelli,David R. D'Adamo,Rachael Scott,Yan Jia,Jagadeesh Aluri,Claudio Favre,Francisco Bautista,Raquel Hladun Alvaro,Ana Sastre Urgelles,Udo KontnyJOURNAL OF CLINICAL ONCOLOGY(2020)引用 1|浏览35暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要